Trials / Completed
CompletedNCT05027061
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
Retrospective Medical Chart Review Study for Non-valvular Atrial Fibrillation Patients Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 11,776 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study is to understand real-world oral anticoagulants (OAC) (warfarin, apixaban, dabigatran, edoxaban and rivaroxaban) usage for non-valvular atrial fibrillation (NVAF) patients.
Conditions
Timeline
- Start date
- 2021-04-02
- Primary completion
- 2021-12-04
- Completion
- 2021-12-04
- First posted
- 2021-08-30
- Last updated
- 2022-03-17
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05027061. Inclusion in this directory is not an endorsement.